Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 2.18 MYR
Change Today -0.02 / -0.91%
Volume 577.6K
YSP On Other Exchanges
Symbol
Exchange
OTC US
As of 4:59 AM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

y.s.p.southeast asia holding (YSP) Snapshot

Open
2.20
Previous Close
2.20
Day High
2.20
Day Low
2.16
52 Week High
05/19/15 - 2.26
52 Week Low
12/16/14 - 1.19
Market Cap
290.5M
Average Volume 10 Days
1.5M
EPS TTM
0.15
Shares Outstanding
133.2M
EX-Date
07/16/14
P/E TM
14.3x
Dividend
0.07
Dividend Yield
2.98%
Current Stock Chart for Y.S.P.SOUTHEAST ASIA HOLDING (YSP)

Related News

No related news articles were found.

y.s.p.southeast asia holding (YSP) Related Businessweek News

No Related Businessweek News Found

y.s.p.southeast asia holding (YSP) Details

Y.S.P. Southeast Asia Holding Berhad, an investment holding company, manufactures, imports, exports, and trades in various kinds of pharmaceutical products. The company offers its products in gels, capsules, tablets, suppositories, creams, syrups, suspensions, and powder dosage forms. It provides prescription products comprising antibacterial and analgesic lozenges, antibiotics, antidiarrheals, antiemetics, antihistamines, antihistamine plus decongestant, antiprotozoal and antiamoebic, antispasmodics, antispasmodics with psycholeptics, drugs for gout therapy, H2-antagonists, antifibrinolytics, nootropics and neurotonics, non-steroidal anti-inflammatory, antipyretics and analgesics, peripheral vasodilators, proton pump inhibitors, and skeletal muscle relaxants; antiasthmatic, anti-diabetic, antifungal, lipid regulating, antihypertensive, antitussive, antiviral, and chemotherapeutics agents, as well as and steroidal, anorectal, and topical preparations. The company also offers non-prescription products, such as anthelmintic agents, antacids, anti-inflammatory enzymes, antipyretics and analgesics, anti-platelet, carminatives, digestive enzymes, expectorants/mucolytic agents, haemorrhoidal, laxatives, and topical preparations; and traditional medicines. In addition, it provides veterinary pharmaceutical products for aquatic and live stock, including anthelmintics, antibiotics, antifungals, anticoccidial agent, antipyretics and analgesics, disinfectants, electrolytes, hematopoietic nutrients, herbal extracts, hormones preparations, probiotics, immune enhancers, vitamins and minerals supplements, antimicrobial, larval feeds, and minerals. Further, the company offers disposables, medical devices, test kits, first aids, medical aids, and insect repellents. It operates in Malaysia, Singapore, the Philippines, Vietnam, Cambodia, Myanmar, Brunei, and other countries. The company was founded in 1987 and is headquartered in Kuala Lumpur, Malaysia.

Founded in 1987

y.s.p.southeast asia holding (YSP) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

y.s.p.southeast asia holding (YSP) Key Developments

Y.S.P. Southeast Asia Holding Berhad Proposes First and Final Single Tier Dividend for the Financial Year Ended December 31, 2014

The Board of Directors of Y.S.P. Southeast Asia Holding Bhd. has proposed the payment of a first and final single tier dividend of 6.5 sen per ordinary share of MYR 1.00 each in respect of the financial year ended 31 December 2014, subject to shareholders' approval at the forthcoming Annual General Meeting of the Company.

Y.S.P. Southeast Asia Holding Berhad Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Year Ended December 31, 2014

Y.S.P. Southeast Asia Holding Berhad reported unaudited consolidated earnings results for the fourth quarter and year ended December 31, 2014. For the quarter, the company’s revenue was MYR 54,924,000 against MYR 48,784,000 a year ago. Results from operating activities were MYR 10,086,000 against MYR 5,548,000 a year ago. Profit before tax was MYR 9,977,000 against MYR 5,540,000 a year ago. Profit attributable to owners of the company was MYR 7,018,000 or 5.27 sen diluted per share against MYR 4,072,000 or 3.06 sen diluted per share a year ago. For the year, the company’s revenue was MYR 202,289,000 against MYR 190,827,000 a year ago. Results from operating activities were MYR 25,589,000 against MYR 22,600,000 a year ago. Profit before tax was MYR 25,230,000 against MYR 22,019,000 a year ago. Profit attributable to owners of the company was MYR 16,492,000 or 12.36 sen diluted per share against MYR 16,191,000 or 12.17 sen diluted per share a year ago. Net cash generated from operating activities was MYR 14,444,000 against MYR 30,022,000 a year ago. Acquisition of property, plant and equipment was MYR 10,655,000 against MYR 4,776,000 a year ago. The decrease in profit before tax was mainly due to a single tier exempt dividend income received from subsidiary in fiscal year 2014 whereas a gross dividend income with 25% tax was received in fiscal year 2013.

Y.S.P. Southeast Asia Holding Berhad Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

Y.S.P. Southeast Asia Holding Berhad reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company’s revenue was MYR 49,821,000 against MYR 46,638,000 a year ago. Results from operating activities were MYR 5,094,000 against MYR 5,497,000 a year ago. Profit before tax was MYR 5,003,000 against MYR 5,363,000 a year ago. Profit attributable to owners of the company was MYR 3,055,000 or 2.30 sen basic per share against MYR 4,167,000 or 3.13 sen basic per share a year ago. For the nine months, the company’s revenue was MYR 147,365,000 against MYR 142,043,000 a year ago. Results from operating activities were MYR 15,503,000 against MYR 17,052,000 a year ago. Profit before tax was MYR 9,897,000 against MYR 12,481,000 a year ago. Profit attributable to owners of the company was MYR 9,474,000 or 7.12 sen basic per share against MYR 12,119,000 or 9.11 sen basic per share a year ago. Net cash generated from operating activities was MYR 7,018,000 against MYR 24,524,000 a year ago. Purchase of property, plant and equipment was MYR 5,813,000 against MYR 3,272,000 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
YSP:MK 2.18 MYR -0.02

YSP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for YSP.
View Industry Companies
 

Industry Analysis

YSP

Industry Average

Valuation YSP Industry Range
Price/Earnings 17.2x
Price/Sales 1.4x
Price/Book 1.2x
Price/Cash Flow 17.2x
TEV/Sales 1.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Y.S.P.SOUTHEAST ASIA HOLDING, please visit www.yspsah.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.